Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 4 for:    self hypnosis and weight loss

The Impact of the Hypnosis on the Loss of Weight at Patients in Failure of Bariatric Surgery (BARIATHYPNOSE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03485469
Recruitment Status : Recruiting
First Posted : April 2, 2018
Last Update Posted : January 10, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier

Brief Summary:
The therapeutic problem of obesity is weight control, a major difficulty, involving a significant change in eating behavior. A number of studies show that there are many factors of resistance to weight loss whether they are physiological, genetic, environmental pressure related, or psychological and behavioral. For some patients, the surgical approach seems the best alternative. Indeed, bariatric surgery is an effective therapeutic weapon in patients with morbid obesity. However, it has been shown that approximately 25% of patients are failing at two years of this surgery (Reinhold's index). Some of the failed subjects may benefit from surgical revision. As for the others, no intervention is currently proposed to them. Studies have shown that the psychological profile of patients who are candidates for bariatric surgery is predominantly impulsive, very anxious with a tendency to depression. The stress level of these patients would be important, and they would have low self-esteem. This study hypothesize that, in these patients, the establishment of hypnotherapeutic management associated with the usual dietary monitoring could modify eating habits thus promoting weight loss and an improvement in self-esteem , stress and anxiety compared to dietary monitoring alone.

Condition or disease Intervention/treatment Phase
Obesity Bariatric Surgery Behavioral: Hypnosis Behavioral: Standard Care Not Applicable

Detailed Description:

he therapeutic problem of obesity is weight control, a major difficulty, involving a significant change in eating behavior. A number of studies show that there are many factors of resistance to weight loss whether they are physiological, genetic, environmental pressure related, or psychological and behavioral. For some patients, the surgical approach seems the best alternative. Indeed, bariatric surgery is an effective therapeutic weapon in patients with morbid obesity. However, it has been shown that approximately 25% of patients are failing at two years of this surgery (Reinhold's index). Some of the failed subjects may benefit from surgical revision. As for the others, no intervention is currently proposed to them. Studies have shown that the psychological profile of patients who are candidates for bariatric surgery is predominantly impulsive, very anxious with a tendency to depression. The stress level of these patients would be important, and they would have low self-esteem. This study hypothesize that, in these patients, the establishment of hypnotherapeutic management associated with the usual dietary monitoring could modify eating habits thus promoting weight loss and an improvement in self-esteem , stress and anxiety compared to dietary monitoring alone.

There are still no studies assessing the impact of hypnotherapeutic management and self-hypnosis on the weight curve, self-esteem, stress, anxiety, or the quality of life of patients Obese in failure of bariatric surgery.

It is an Interventional, prospective, multi-center, controlled, randomized, open-label study with 2 parallel arms, evaluating the efficacy of hypnotherapeutic management in patients with bariatric surgery failure, compared to dietary monitoring alone.

Number of visits: 13 visits are planned: 1 visit of inclusion, a visit ensuring the first dietary follow-up, 9 hypnosis sessions (for the experimental group), two visits dedicated to the collection of the judgment criteria. Each patient is followed for 12 months.

The estimated duration of recruitment is 18 months.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Prospective Randomized Clinical Trial, in Open-label, Multicenter, Estimating the Impact of the Hypnosis on the Loss of Weight at Patients in Failure of Bariatric Surgery
Actual Study Start Date : March 29, 2019
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : October 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Usual Care
The control group will benefit from a standard care dietary consultation in the service and 9 dietary consultations by phone every 15 days.
Behavioral: Standard Care
The dietary advice given during these dietary consultations is part of the standard care adapted to patients who have undergone bariatric surgery while increasing the frequency of consultations (Fractionation of meals, Volume of meals, Taking meals, Drinks, Food diversity)

Hypnosis
The experimental group will benefit from a dietary consultation in the service, 9 dietary consultations by telephone every 15 days to which will be associated 7 individual sessions of hypnosis and 3 individual sessions of learning to autohypnosis. A recording containing the induction of a self-hypnosis session will be given to the subject at the end of the 10 sessions, in order to promote the continuation of home-made autohypnosis.
Behavioral: Hypnosis

There ar 10 hypnosis sessions :

  • 1st session of hypnosis : relaxation and orientation towards "emotional cleansing".
  • 2nd session of hypnosis: oriented towards digestion, physical and psychological
  • 3rd session of hypnosis: oriented towards the feeling of security.
  • 4th session of hypnosis: self-esteem oriented.
  • 5th hypnosis session: oriented towards emotional management.
  • 6th hypnosis session: oriented towards self-confidence.
  • 7th hypnosis session: oriented towards the completion of the projects.
  • 8th, 9th and 10th sessions: concern the learning of self-hypnosis and autonomy. A USB key containing the induction of a session of autohypnosis will be given to the subject to promote the continuation of home-made auto-hypnosis.




Primary Outcome Measures :
  1. Change in weight in 5 months [ Time Frame: 5 months ]
    Patient weight (in kg) measurement will be performed on the same scale by staff who are unaware of the patient's randomization group.


Secondary Outcome Measures :
  1. Change in weight in 12 months [ Time Frame: 12 months ]
    Patient weight (in kg) measurement will be performed on the same scale by staff who are unaware of the patient's randomization group.

  2. Self-esteem [ Time Frame: 12 months ]
    It will be evaluated by the scale of "Rosenberg's Self Esteem Scale" (1965) validated in French. It represents an assessment of the overall self-esteem that the person can have of herself. The scale includes 10 statements measured on a scale of 1 to 4.

  3. Evolution of Quality of life [ Time Frame: 12 months ]
    it will be evaluated by the variation of the scores obtained in the self-questionnaire EQVOD (Echelle de Qualité de Vie, Obésité et Diététique) of O. Ziegler et al (2005). It's a specific quality of life questionnaire for obese people.

  4. Anxiety and depressive state [ Time Frame: 12 months ]
    It will be evaluated by the Hospital Anxiety and Depression Scale - HAD (Sigmond et al, 1983). It is a self-administered 14-item questionnaire that assesses the current level of depressive and anxious symptomatology by eliminating somatic depressions that may skew assessments.

  5. Feeding behavior [ Time Frame: 12 months ]

    It will be evaluated by the TFEQ-R21 (Three-Factor Eating Questionnaire) self-questionnaire (Cappelleri et al, 2009).

    TFEQ has been validated in the general population and has been used in many studies. It explores three components of eating behavior: cognitive restriction, uncontrolled eating, and emotional eating.


  6. Patients' satisfaction with their care [ Time Frame: 12 months ]
    It will be evaluated the Likert scales of the self-satisfaction questionnaire. It is composed of 5 Likert scales coded from 1 to 5 which will be analyzed separately



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • Obese patient (BMI = 30 kg / m ²)
  • 18 - 65 years ( inclusive borders)
  • Patient in failure of bariatric surgery and in which no surgical resumption can be proposed (in view of Reinhold's classification, the failure will be considered as a loss of overweight lower than 50 % in two years further to a bariatric surgery).
  • Informed consent
  • Patient in measure to realize all the visits and to follow the procedures of the study - Subject affiliated to a social security system

Exclusion criteria:

  • Pregnancy current or planned during the duration of the study, pregnant or breast-feeding women
  • Craniopharyngioma or any other evolutionary malignant pathology, or chronic illness in decompensation phase
  • Strong probability of not compliance to the protocol or drop-out
  • Psychiatric pathology of dissociated type (schizophrenia; psychosis, bipolarity …)
  • Sensory (hearing, visual) or cognitive deficits susceptible to hinder the progress of the sessions.
  • Incapacity to understand the nature and the purpose of the study and\or communication difficulties with the investigator
  • Patient having already benefited from a coverage by hypnotherapy for loss of weight
  • Taken by treatment having an impact on the loss of weight (corticoid, antithyroid …)
  • Major protected by the law or considered vulnerable (under guardianship)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03485469


Contacts
Layout table for location contacts
Contact: Cécile GODEL, Dietetician 04.67.33.79.52 ext +33 c-godel@chu-montpellier.fr
Contact: Mélanie DELOZE, CRA m-deloze@chu-montpellier.fr

Locations
Layout table for location information
France
CHR Saint Pierre - maladies métaboliques Recruiting
La Réunion, France
Contact: Nathalie LEMOULEC         
Cécile GODEL Recruiting
Montpellier, France
Contact: Cécile GODEL, Dietetician    04.67.33.79.52    c-godel@chu-montpellier.fr   
Contact: Mélanie DELOZE, CRA       m-deloze@chu-montpellier.fr   
Orléans University Hospital Recruiting
Orléans, France
Contact: Elise MONGEOIS         
Reims University Hospital Recruiting
Reims, France
Contact: Eric BERTIN         
Toulouse University Hospital Recruiting
Toulouse, France
Contact: Patrick RITZ         
Sponsors and Collaborators
University Hospital, Montpellier
Investigators
Layout table for investigator information
Principal Investigator: David NOCCA, PU-PH University Hospital, Montpellier
Layout table for additonal information
Responsible Party: University Hospital, Montpellier
ClinicalTrials.gov Identifier: NCT03485469    
Other Study ID Numbers: RECHMPL17_0024
UF 9793 ( Other Identifier: Montpellier University Hospital )
First Posted: April 2, 2018    Key Record Dates
Last Update Posted: January 10, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Montpellier:
Obesity
bariatric surgery
Hypnosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity
Weight Loss
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Body Weight Changes